Gen-Probe, Inc. (NASDAQ:GPRO)

CAPS Rating: 3 out of 5

The Company is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid probe-based products used for the clinical diagnosis of human diseases and for screening donated human blood.

Featured Broker Partners


Advertisement